Topics
Glioblastoma | Etiopathogenesis | Resistance
Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Resistance
Chang
C, Chavarro VS, Gerstl JVE, Blitz SE, Spanehl L, Dubinski D,
Valdes PA, Tran LN, Gupta S, Esposito L, Mazzetti D, Gessler FA,
Arnaout O, Smith TR, Friedman GK, Peruzzi P, Bernstock JD.
Recurrent
Glioblastoma-Molecular Underpinnings and Evolving Treatment
Paradigms.
Int
J Mol Sci.
2024 Jun 19;25(12):6733. doi:
10.3390/ijms25126733. PMID:
38928445.
Review. ˍ
Palizkaran
Yazdi M, Barjasteh A, Moghbeli M.
MicroRNAs
as the pivotal regulators of Temozolomide resistance in
glioblastoma.
Mol
Brain.
2024 Jul 2;17(1):42. doi:
10.1186/s13041-024-01113-6. PMID:
38956588. Review. ˍ
Sherman JH, Bobak A, Arsiwala T, Lockman P, Aulakh S.
Targeting
drug resistance
in glioblastoma (Review).
Int
J Oncol. 2024 Jul 9;65(2):80. doi:
10.3892/ijo.2024.5668. PMID:
38994761.
Review. ˍ